ERAS Reports $12M Revenue, $0.05 EPS, Announces $20M Buyback, RAS-Mutant Data Call, RevMed IP Threat
Erasca, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $13.82
-48% in 1d after detection
Post-detection moves
1h
—
1d
-48%
3d
-44%
7d
-43%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS